Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center, addresses major unmet needs in Fabry disease, ranging from uncontrolled pain to irreversible damage prior to treatment initiation.
With no current treatments available to reverse the damage caused by Fabry disease, unmet needs in patients also include management of pain, gastrointestinal, and sleepiness issues, said Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center.
Transcript
What are some unmet challenges regarding management of Fabry disease?
The treatments that we have right now are well studied and they slow down the progression of kidney disease and heart disease reasonably well, and that's well documented. But the treatments don't appear to adequately control the pain, which is a major quality-of-life issue.
They also don't reverse the damage that's already been done. So, the current average age for starting therapy for Fabry disease is about age 30. By that age, people with the classic severe form of Fabry disease will already have some irreversible damage to kidneys and/or heart in many cases. We need to get earlier recognition.
So, pain management, early recognition. We need earlier and more effective treatment for the lymphedema, earlier more effective treatment for the GI [gastrointestinal] symptoms. Hearing loss is something that is not well studied, but does impact a significant number of patients. And then the fatigue and sleepiness issues.
All of those are essentially unaddressed at this point—other than the people who are very interested in Fabry disease, treating patients on an individual basis as best they can for those problems.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen